Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on chiral free synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a 3-step, high-yield synthesis of dimethylorphin phosphate with no chiral resolution. Reduce costs and scale efficiently for your antitussive drug supply chain.
Solve chiral resolution challenges in moxifloxacin manufacturing with this patent-validated method. Achieve 80%+ yields, reduce costs, and ensure supply chain stability for your API production.
Discover a chiral resolution-free synthesis for moxifloxacin with high yield and purity. Reduce production costs and supply chain risks for your API manufacturing.
Solve chiral resolution challenges in avacopan synthesis with 63.59% yield and 98.8% ee. Reduce costs and scale efficiently for clinical and commercial supply.
Solve low enantioselectivity & high catalyst cost in alpha-hydroxy-beta-keto ester production. 97% ee, 95% yield, 5-25 mol% catalyst. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Discover scalable synthesis of N-N axis chiral pyrrole derivatives with >94% ee and high QGP-1 cytotoxicity. Eliminate costly chiral separation steps. Request COA/MSDS now.